IBIO
iBioBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
IBIO vs peer average
77/100
IBIO vs. peer average (B vs. D)
Grade spread
A 1 · B 2 · D 3 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LPCN is the first available peer comparator.
Lipocine is a looser peer scientifically, but it still helps frame how micro-cap biotech equities remain highly catalyst- and financing-dependent.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IBIO
iBio
LPCN
Lipocine
Grade
B
A
Momentum
96
100
Value
41
42
Sentiment
34
45
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs LPCN
IBIO / LPCN
Grade Position
Above peers
IBIO vs. peer average (B vs. D)
77/100
Momentum
96
LPCNValue
41
LPCNSentiment
34
LPCNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IBIO
LPCN is the first peer returned for this comparison set.